| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 63.86B | 64.93B | 63.74B | 43.63B | 40.76B | 37.12B |
| Gross Profit | 5.08B | 5.44B | 5.68B | 3.67B | 2.98B | 3.01B |
| EBITDA | 4.34B | 5.06B | 4.98B | 3.68B | 2.39B | 3.05B |
| Net Income | 618.65M | -2.11B | 766.00M | 632.95M | -1.14B | 513.57M |
Balance Sheet | ||||||
| Total Assets | 56.30B | 57.04B | 56.06B | 53.19B | 42.62B | 38.54B |
| Cash, Cash Equivalents and Short-Term Investments | 8.20B | 8.57B | 7.68B | 6.21B | 5.53B | 4.86B |
| Total Debt | 29.82B | 30.80B | 29.01B | 26.73B | 22.55B | 18.88B |
| Total Liabilities | 44.30B | 47.35B | 43.94B | 41.76B | 31.63B | 28.21B |
| Stockholders Equity | 12.00B | 9.69B | 12.12B | 11.43B | 10.99B | 10.32B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 396.22M | 315.94M | 2.32B | -1.09B | 2.34B |
| Operating Cash Flow | 0.00 | 4.12B | 3.51B | 4.83B | 1.61B | 3.82B |
| Investing Cash Flow | 0.00 | -4.40B | -3.16B | -4.52B | -4.24B | -1.42B |
| Financing Cash Flow | 0.00 | 1.19B | 1.09B | 436.06M | 3.35B | -4.56B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥133.77B | 17.24 | ― | 1.78% | 2.28% | 4.19% | |
68 Neutral | ¥38.72B | 14.56 | ― | 1.42% | 7.06% | 38.85% | |
66 Neutral | ¥20.80B | 7.10 | ― | 0.76% | 18.01% | -2.49% | |
64 Neutral | ¥380.07B | 17.60 | 10.65% | 1.64% | 5.49% | 3.58% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
55 Neutral | ¥6.39B | 15.09 | ― | 2.41% | 0.03% | -0.59% | |
54 Neutral | ¥18.88B | -9.52 | ― | 1.12% | 1.88% | -376.58% |